Quality Compounder

556 tickers in this investment thesis
Ranks this page's recent reports by score.
Novartis AG
NVS·Healthcare
B ★★★Hold
Current$161.10
Target$169.15
Return+5.0%
Oct 30, 2026

Novartis combines a profitable innovative-medicines franchise with growing oncology and immunology treatments, but patent erosion, acquisition-related clinical failures, and an elevated historical cash-flow valuation constrain upside.

Score
68
Chubb Limited
CB·Financials
B ★★★Hold
Current$362.28
Target$382.98
Return+5.7%
Oct 30, 2026

Chubb's disciplined underwriting, strong investment income, and consistent capital returns support durable long-term compounding, although elevated historical book-value multiples and insurance pricing cycles constrain near-term upside.

Score
73
CSX Corporation
CSX·Industrials
B ★★★Hold
Current$51.98
Target$52.80
Return+1.6%
Oct 29, 2026

CSX's irreplaceable eastern U.S. railroad network and improving operating margins support long-term earnings resilience, but its elevated valuation and cyclical freight exposure limit near-term upside.

Score
69
Coca-Cola FEMSA, S.A.B. de C.V.
KOF·Consumer Staples
B ★★★Hold
Current$115.24
Target$119.00
Return+3.3%
Oct 29, 2026

Coca-Cola FEMSA combines a durable Latin American beverage distribution moat with attractive capital returns and dividends, but its elevated historical valuation and Mexican margin pressure limit near-term upside.

Score
71
The Hartford Insurance Group, Inc.
HIG·Financials
A ★★★★Buy
Current$130.04
Target$150.70
Return+15.9%
Oct 29, 2026

Hartford offers profitable commercial insurance underwriting, strong core ROE and shareholder-friendly capital returns at a reasonable forward earnings valuation, although claims inflation and catastrophe losses could weaken normalized profitability.

Score
80
Brown & Brown, Inc.
BRO·Financials
B ★★★Hold
Current$65.88
Target$76.64
Return+16.3%
Oct 29, 2026

Brown & Brown combines recurring insurance brokerage cash flow with an unusually discounted valuation, but weak organic growth, specialty insurance pricing pressure, and acquisition leverage could delay a sustained earnings recovery.

Score
74
Cincinnati Financial Corporation
CINF·Financials
B ★★★Hold
Current$179.39
Target$186.45
Return+3.9%
Oct 29, 2026

Cincinnati Financial combines disciplined underwriting, durable agency relationships and reliable dividend growth, but its elevated historical book-value multiple and catastrophe exposure limit near-term upside.

Score
73
Dorman Products, Inc.
DORM·Consumer Discretionary
A ★★★★Buy
Current$129.74
Target$145.44
Return+12.1%
Oct 29, 2026

Dorman Products combines a defensible aftermarket franchise, recurring vehicle repair demand, and attractive capital returns with reasonable valuation, although tariff-driven margin volatility and modest organic growth constrain near-term upside.

Score
77
Simpson Manufacturing Co., Inc.
SSD·Materials
B ★★★Hold
Current$189.02
Target$205.80
Return+8.9%
Oct 29, 2026

Simpson's engineering-driven structural-products franchise generates attractive returns and resilient cash flow, but cyclical housing demand and a moderately demanding valuation limit near-term upside.

Score
72
Logitech International S.A.
LOGI·Technology
A ★★★★Buy
Current$98.27
Target$110.20
Return+12.1%
Oct 29, 2026

Logitech combines leading peripheral brands, strong free cash flow, and a resilient net cash balance sheet with an attractive valuation, although semiconductor supply disruptions and competitive hardware markets threaten near-term earnings.

Score
79
W. R. Berkley Corporation
WRB·Financials
B ★★★Hold
Current$72.38
Target$75.75
Return+4.7%
Oct 28, 2026

W. R. Berkley's disciplined specialty underwriting and strong operating ROE support long-term book-value compounding, but a historically elevated valuation and slowing premium growth limit near-term upside.

Score
69